The Precision Peptide Company Inc. PNGAF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -168.20% | -87.62% | -623.85% | -594.47% | -833.46% |
| Total Depreciation and Amortization | -- | -- | -- | 1,485.71% | 3,733.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,450.98% | -- | -- | 4,693.02% | 18.15% |
| Change in Net Operating Assets | -502.60% | -48.61% | 312.82% | -294.63% | 225.36% |
| Cash from Operations | -314.96% | -59.38% | -219.51% | -710.83% | -3,830.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 412.94% | 68.36% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 188.26% | 68.36% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 461.80% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 74.40% | -92.16% | -39.67% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.66% | 85.88% | -92.08% | -16.97% | -- |
| Foreign Exchange rate Adjustments | -521.82% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.45% | 661.24% | -886.23% | -664.03% | 18,050.00% |